Patients with EDA during follow-up after AHSCT had higher concentrations of CCL3, IL-8 and CXCL10 at baseline (all P < 0.05), in comparison to patients with NEDA (Fig. 5). The gene discussed is CXCL10; the disease is hypohidrotic ectodermal dysplasia.